Dyslipidemia is a persistent problem in puerperium with or without preeclampsia

Area of Science:

• Obstetrics and Gynecology
• Cardiovascular Health
• Metabolic Disorders

Background:

• Preeclampsia is a serious pregnancy complication.
• Dyslipidemia, characterized by abnormal lipid levels, is a concern postpartum.
• Chronic endothelial disease (CED) is a potential long-term consequence of cardiovascular and metabolic disturbances.

Purpose of the Study:

• To compare serum triglyceride and cholesterol levels in puerperal women with and without preeclampsia.
• To evaluate the utility of the dyslipidemic factor (DLF) in assessing lipid profiles postpartum.
• To explore the relationship between preeclampsia, dyslipidemia, and the risk of developing CED.

Main Methods:

• A study involving 47 puerperal women divided into three groups: uncomplicated deliveries, preeclampsia without OICU admission, and preeclampsia with OICU admission.
• Serum triglyceride and cholesterol levels were measured.
• The dyslipidemic factor (DLF) was calculated as (triglycerides/150) X (cholesterol/200).

Main Results:

• A high prevalence of hypertriglyceridemia (triglycerides > 150 mg/dl) was observed in all groups postpartum.
• 100% of puerperal women with preeclampsia had elevated triglycerides.
• Elevated DLF levels ('in crescendo') were noted in 42.8% of uncomplicated cases, 9% with preeclampsia, and 36.3% with severe preeclampsia requiring OICU care.

Conclusions:

• Hypertriglyceridemia persists in puerperal women following preeclampsia.
• The DLF may serve as a valuable tool for identifying mixed lipemic states.
• Preeclampsia and dyslipidemia are potential risk factors for the development of chronic endothelial disease.